EQIX vs VRTX · P/E 79, rev $5.07B vs P/E 30, rev $3.33B
Equinix Inc (EQIX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the EQIX and VRTX stock pages for the full models.
Not investment advice.